Avidor B, Golenser J, Sulitzeanu D
J Immunol Methods. 1985 Sep 3;82(1):121-9. doi: 10.1016/0022-1759(85)90231-5.
An antibody binding-inhibition test is described, which allows the detection of P. falciparum in red blood cells (RBC) infected in vitro, using a crossreacting, monoclonal anti-P. berghei antibody and P. berghei coated microtiter plates. Experiments carried out to determine the coating efficiency of various P. berghei and P. falciparum derived antigen preparations showed that intact, saponin freed P. berghei parasites and sonicated, RBC parasitized with P. falciparum had the highest binding activity. Binding of the monoclonal antibody to the antigen coated plates was effectively inhibited by preincubation with sonicated, P. falciparum infected RBC. The minimal degree of infection detectable was about 0.008% parasitemia (400 parasitized RBC/microliters blood). The sensitivity of detection was not appreciably affected by the source of the coating antigen. We conclude that the difficulty and expense involved in the use of P. falciparum based immunodiagnostic tests for large scale screening for malaria can be obviated by making use of P. berghei based assays.
本文描述了一种抗体结合抑制试验,该试验利用交叉反应的抗伯氏疟原虫单克隆抗体和包被有伯氏疟原虫的微量滴定板,检测体外感染疟原虫的红细胞中的恶性疟原虫。为确定各种源自伯氏疟原虫和恶性疟原虫的抗原制剂的包被效率而进行的实验表明,完整的、经皂素处理的伯氏疟原虫寄生虫以及经超声处理的、感染恶性疟原虫的红细胞具有最高的结合活性。用超声处理的、感染恶性疟原虫的红细胞预孵育可有效抑制单克隆抗体与包被抗原的板的结合。可检测到的最低感染程度约为0.008%的疟原虫血症(每微升血液中有400个被寄生的红细胞)。检测灵敏度不受包被抗原来源的明显影响。我们得出结论,通过使用基于伯氏疟原虫的检测方法,可以避免使用基于恶性疟原虫的免疫诊断试验进行大规模疟疾筛查所涉及的困难和费用。